Asia Pacific T Cell Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific T Cell Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific T Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific T Cell Therapy Market Regional Analysis

6.2 Asia Pacific T Cell Therapy Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific T Cell Therapy Market Forecast Analysis

7. Asia Pacific T Cell Therapy Market Analysis – by Modality

7.1 Research

7.1.1 Overview
7.1.2 Research: Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Commercialized

7.2.1 Overview
7.2.2 Commercialized: Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific T Cell Therapy Market Analysis – by Therapy Type

8.1 CAR T-cell Therapy

8.1.1 Overview
8.1.2 CAR T-cell Therapy: Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 T-cell Receptor-based

8.2.1 Overview
8.2.2 T-cell Receptor-based: Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific T Cell Therapy Market Analysis – by Indication

9.1 Hematologic Malignancies

9.1.1 Overview
9.1.2 Hematologic Malignancies: Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Solid Tumors

9.2.1 Overview
9.2.2 Solid Tumors : Asia Pacific T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific T Cell Therapy Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific T Cell Therapy Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Asia Pacific T Cell Therapy Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 China: Asia Pacific T Cell Therapy Market Breakdown, by Modality
10.2.1.1.2 China: Asia Pacific T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.1.3 China: Asia Pacific T Cell Therapy Market Breakdown, by Indication

10.2.1.2 India: Asia Pacific T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 India: Asia Pacific T Cell Therapy Market Breakdown, by Modality
10.2.1.2.2 India: Asia Pacific T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.2.3 India: Asia Pacific T Cell Therapy Market Breakdown, by Indication

10.2.1.3 Japan: Asia Pacific T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific T Cell Therapy Market Breakdown, by Modality
10.2.1.3.2 Japan: Asia Pacific T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.3.3 Japan: Asia Pacific T Cell Therapy Market Breakdown, by Indication

10.2.1.4 Australia: Asia Pacific T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific T Cell Therapy Market Breakdown, by Modality
10.2.1.4.2 Australia: Asia Pacific T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.4.3 Australia: Asia Pacific T Cell Therapy Market Breakdown, by Indication

10.2.1.5 Rest of Asia-Pacific : Asia Pacific T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific T Cell Therapy Market Breakdown, by Modality
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific T Cell Therapy Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Bristol-Myers Squibb Co

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Gilead Sciences Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Innovent Biologics Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Janssen Global Services LLC

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 JW (Cayman) Therapeutics Co Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Legend Biotech Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novartis AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific T Cell Therapy Market

Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)